Sale!

PINK1 Gene PARK6 Parkinson Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PINK1 Gene PARK6 Parkinson Genetic Test is a specialized diagnostic examination designed to detect mutations in the PTEN-induced kinase 1 (PINK1) gene, which is associated with PARK6, a form of early-onset Parkinson’s disease. This genetic test is crucial for individuals with a family history of Parkinson’s disease or those who exhibit symptoms at an early age, as it can provide definitive information regarding their genetic predisposition to this form of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis to identify the specific mutations in the PINK1 gene that are linked to the development of Parkinson’s disease. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret the genetic variations associated with the condition. This test not only aids in the early diagnosis and understanding of the patient’s condition but also in the planning of personalized management and treatment strategies, potentially improving the quality of life for those affected by this form of Parkinson’s disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PINK1 Gene PARK6 Parkinson Genetic Test

Are you or a loved one experiencing symptoms of Parkinson’s disease? DNA Labs UAE offers the PINK1 Gene PARK6 Parkinson Genetic Test to help diagnose and understand this condition. Read on to learn more about this test, its cost, symptoms, diagnosis, and other important details.

Test Name: PINK1 Gene PARK6 Parkinson Genetic Test

Components: This test includes the analysis of the PINK1 gene.

Price: AED 4400.0

Sample Condition: The test can be performed using blood or extracted DNA. Alternatively, one drop of blood can be collected on an FTA Card.

Report Delivery: The test results will be delivered within 3 to 4 weeks.

Method: The PINK1 Gene PARK6 Parkinson Genetic Test utilizes NGS (Next-Generation Sequencing) technology.

Test Type: This test is specifically designed to diagnose neurological disorders, such as Parkinson’s disease.

Doctor: The test is conducted under the supervision of a neurologist.

Test Department: This test is performed in the Genetics department.

Pre Test Information

Before undergoing the PINK1 Gene PARK6 Parkinson Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by PINK1 Gene PARK6 Parkinson.

Test Details

The PINK1 gene is responsible for producing a protein called PTEN-induced putative kinase 1. Mutations in the PINK1 gene are associated with a specific type of Parkinson’s disease known as PARK6. This form of Parkinson’s disease typically manifests before the age of 40 and is characterized by symptoms such as tremors, muscle stiffness, difficulty with movement and balance, and cognitive impairment.

NGS (Next-Generation Sequencing) genetic testing is a sophisticated method that allows for the analysis of multiple genes simultaneously. By utilizing advanced sequencing technologies, NGS genetic testing can rapidly and accurately sequence large amounts of DNA. In the case of Parkinson’s disease, NGS genetic testing can identify mutations in genes linked to the condition, including the PINK1 gene.

NGS genetic testing for the PINK1 gene is crucial in diagnosing PARK6 Parkinson’s disease and providing information about the specific genetic mutation causing the disease. This information can be beneficial for genetic counseling, family planning, and potentially guiding treatment decisions.

It is important to note that genetic testing for Parkinson’s disease is not typically conducted as a routine diagnostic test. It is usually reserved for individuals with a strong family history of early-onset Parkinson’s disease or for research purposes. It is highly recommended to undergo genetic testing under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling.

Test Name PINK1 Gene PARK6 Parkinson Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PINK1 Gene PARK6 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PINK1 Gene PARK6 Parkinson
Test Details

The PINK1 gene is a gene that provides instructions for making a protein called PTEN-induced putative kinase 1. Mutations in the PINK1 gene are associated with a form of Parkinson’s disease known as PARK6.

PARK6 is an early-onset form of Parkinson’s disease that typically begins before the age of 40. It is characterized by symptoms such as tremors, muscle stiffness, difficulty with movement and balance, and cognitive impairment.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes simultaneously. It uses advanced sequencing technologies to rapidly and accurately sequence large amounts of DNA. In the context of Parkinson’s disease, NGS genetic testing can be used to identify mutations in genes associated with the condition, including the PINK1 gene.

NGS genetic testing for the PINK1 gene can help diagnose PARK6 Parkinson’s disease and provide information about the specific genetic mutation causing the disease. This information can be useful for genetic counseling, family planning, and potentially guiding treatment decisions.

It’s important to note that genetic testing for Parkinson’s disease is not typically performed as a routine diagnostic test. It is usually reserved for individuals with a strong family history of early-onset Parkinson’s disease or for research purposes. Genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling.